Satoko Ito

679 total citations
62 papers, 364 citations indexed

About

Satoko Ito is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Satoko Ito has authored 62 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Hematology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Satoko Ito's work include Palliative Care and End-of-Life Issues (9 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Complement system in diseases (4 papers). Satoko Ito is often cited by papers focused on Palliative Care and End-of-Life Issues (9 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Complement system in diseases (4 papers). Satoko Ito collaborates with scholars based in Japan, United States and South Korea. Satoko Ito's co-authors include Yoichi Watanabe, Tomohiro Saito, Osami Kubo, Shigeru Sokejima, Jun Hagihara, Seiichiro Yamamoto, Shin Yamazaki, Yosikazu Nakamura, Katsuo Isaka and Akira Eboshida and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Satoko Ito

53 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoko Ito Japan 10 81 59 58 54 51 62 364
Giorgio Tettamanti Sweden 13 61 0.8× 141 2.4× 51 0.9× 98 1.8× 51 1.0× 42 435
Camilla Pedersen Denmark 14 102 1.3× 89 1.5× 36 0.6× 77 1.4× 89 1.7× 27 463
Sona Oksuzyan United States 11 289 3.6× 112 1.9× 39 0.7× 77 1.4× 191 3.7× 16 507
Katherine S. Hunt United States 11 26 0.3× 80 1.4× 67 1.2× 113 2.1× 6 0.1× 17 565
Dana R. Friedman United States 7 314 3.9× 109 1.8× 80 1.4× 77 1.4× 203 4.0× 11 556
Hamidah Alias Malaysia 14 10 0.1× 187 3.2× 81 1.4× 91 1.7× 36 0.7× 71 541
Badereddin Mohamad Al–Ali Austria 10 51 0.6× 32 0.5× 24 0.4× 86 1.6× 3 0.1× 26 326
Karl Gerhard Blaasaas Norway 13 265 3.3× 70 1.2× 15 0.3× 54 1.0× 124 2.4× 21 500
Carol M. Haines United States 7 325 4.0× 104 1.8× 23 0.4× 81 1.5× 193 3.8× 12 540
K. E. von Mühlendahl Germany 7 64 0.8× 68 1.2× 7 0.1× 13 0.2× 24 0.5× 40 380

Countries citing papers authored by Satoko Ito

Since Specialization
Citations

This map shows the geographic impact of Satoko Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoko Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoko Ito more than expected).

Fields of papers citing papers by Satoko Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoko Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoko Ito. The network helps show where Satoko Ito may publish in the future.

Co-authorship network of co-authors of Satoko Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Satoko Ito. A scholar is included among the top collaborators of Satoko Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoko Ito. Satoko Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Satoko, Jeremy N. Harvey, Jan Philipp Bewersdorf, et al.. (2025). Prophylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in People Living With Severe Hemophilia A. Annals of Internal Medicine. 178(6). 819–828.
2.
Ito, Satoko, Robert Bona, Harlan M. Krumholz, et al.. (2025). Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis. Blood Advances. 9(24). 6237–6245. 1 indexed citations
3.
Mendiratta, Gaurav, et al.. (2024). Cancer research is not correlated with driver gene mutation burdens. Med. 5(7). 832–838.e4.
4.
Ito, Satoko, et al.. (2024). Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura. Blood Advances. 8(9). 2279–2289. 1 indexed citations
5.
Ito, Satoko, Daniel Wang, Harlan M. Krumholz, et al.. (2024). Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria. Blood. 145(1). 127–140. 3 indexed citations
6.
Wang, Daniel, Satoko Ito, Ellen Zhang, et al.. (2024). Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood Advances. 8(11). 2835–2845. 4 indexed citations
7.
Ito, Satoko, Ankur Pandya, Ronald G. Hauser, et al.. (2024). Decreasing alloimmunization‐specific mortality in sickle cell disease in the United States: Cost‐effectiveness of a shared transfusion resource. American Journal of Hematology. 99(4). 570–576. 2 indexed citations
8.
10.
Kobayashi, Sayaka, et al.. (2023). Characterization of the stanford integrated psychosocial assessment for transplant for heart, liver, and kidney transplant candidates in Japan. BioPsychoSocial Medicine. 17(1). 24–24. 3 indexed citations
11.
Kobayashi, Sayaka, et al.. (2023). Association of the Stanford Integrated Psychosocial Assessment for Transplant and 1-Year Outcome of Living Kidney Transplantation in Japan. Journal of the Academy of Consultation-Liaison Psychiatry. 65(1). 14–24. 2 indexed citations
13.
Koike, Daisuke, et al.. (2020). A case of Japanese spotted fever. 124(8). 1279.
14.
Wakiguchi, Hiroyuki, et al.. (2016). A Sporadic Neonatal Case of Epidermolysis Bullosa Simplex Generalized Intermediate with KRT5 and KRT14 Gene Mutations. American Journal of Perinatology Reports. 6(1). e108–e111. 4 indexed citations
15.
Miyaoka, Youichi, Sayaka Ueno, Satoshi Yamanouchi, et al.. (2015). A CASE OF EOSINOPHILIC ESOPHAGITIS COMPLICATED WITH CROHN'S DISEASE. Acta gastro-enterologica belgica. 57(2). 128–133. 2 indexed citations
16.
Fujita, Hidenori, Kazutaka Miyadera, Masanori Kato, et al.. (2013). The Novel VEGF Receptor/MET–Targeted Kinase Inhibitor TAS-115 Has Marked In Vivo Antitumor Properties and a Favorable Tolerability Profile. Molecular Cancer Therapeutics. 12(12). 2685–2696. 30 indexed citations
17.
Sawaki, Akira, Noriyuki Hoki, Satoko Ito, et al.. (2009). Clinical impact of radiotherapy for locally advanced pancreatic cancer. Journal of Gastroenterology. 44(12). 1209–1214. 9 indexed citations
18.
Watanabe, Yoichi & Satoko Ito. (2007). Influence of Vehicle Properties and Human Attributes on Neck Injuries in Rear-End Collisions. 20th International Technical Conference on the Enhanced Safety of Vehicles (ESV)National Highway Traffic Safety Administration. 14 indexed citations
19.
Ito, Satoko, et al.. (2006). Virus-like particles associated with mass mortalities of the pen shell Atrina pectinata in Japan. Diseases of Aquatic Organisms. 71(2). 169–173. 21 indexed citations
20.
Kabuto, Michinori, Hiroshi Nitta, Seiichiro Yamamoto, et al.. (2006). Childhood leukemia and magnetic fields in Japan: A case‐control study of childhood leukemia and residential power‐frequency magnetic fields in Japan. International Journal of Cancer. 119(3). 643–650. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026